CHD-risk factors
Showing 1 - 25 of >10,000
Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27
Completed
- Coronary Disease
- MK0653, ezetimibe / Duration of Treatment: 27 Weeks
- +2 more
- (no location specified)
Feb 7, 2022
Procedure for Adjustment of Risk Factors in Coronary Heart
Recruiting
- Coronary Artery Disease
- +3 more
- CHD therapy through iATROS medical device
-
Munich, Bayern, GermanyKlinikum der Ludwig-Maximilians-Universität München (Klinikum de
Oct 18, 2023
sessmenT and treAtment In AustraliaN Primary Care
Not yet recruiting
- Atherosclerotic Cardiovascular Disease (ASCVD)
- +3 more
- Inclisiran Prefilled Syringe
-
Clayton, Victoria, AustraliaMonash Health
Apr 17, 2023
Genetic Markers of CHD Risk in Men and Women
Completed
- Cardiovascular Diseases
- +4 more
- (no location specified)
Apr 13, 2021
AKI, CHD - Congenital Heart Disease, Surgery Trial in Cincinnati (Nitric Oxide, Oxygen)
Recruiting
- AKI
- +2 more
- Nitric Oxide
- Oxygen
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Apr 6, 2022
On Liprimar In Coronary Heart Disease And High Risk Of
Completed
- Cardiovascular Diseases
- Coronary Artery Disease
- (no location specified)
Feb 16, 2021
Dermatitis, Atopic Trial in France (PREBIOTICS, PLACEBO)
Recruiting
- Dermatitis, Atopic
- PREBIOTICS
- PLACEBO
-
Angers, France
- +5 more
Jun 11, 2021
Coronary Heart Disease Trial in Germany, United States (Placebo, dalcetrapib)
Coronary Heart Disease Trial in Worldwide (Placebo, dalcetrapib)
Multiple Myeloma Trial in France (Carfilzomib, Daratumumab, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +3 more
-
Nantes, Pays De La Loire, France
- +11 more
Apr 27, 2021
Fitness Trackers, Sedentary Time, Genetic Predisposition to Disease Trial (Genetic Risk Estimate+Health Coaching, Genetic Risk
Not yet recruiting
- Fitness Trackers
- +3 more
- Genetic Risk Estimate+Health Coaching
- Genetic Risk Estimate + Fitbit Functions+Health Coaching
- (no location specified)
Mar 16, 2023
Frailty and Non-Fragile Congenital Heart Disease
Not yet recruiting
- Congenital Heart Disease
- Frailty
- Observational
- (no location specified)
Apr 10, 2023
Using Digital Data to Predict CHD
Recruiting
- Cardiovascular Diseases
- Survey
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Jan 7, 2022
Coronary Heart Disease, Cardiovascular Risk Factor, Arterial Stiffness Trial in Loughborough (Exercise)
Completed
- Coronary Heart Disease
- +4 more
- Exercise
-
Loughborough, United KingdomLoughborough University
Aug 16, 2022
Cardiovascular Primary Prevention Strategy Trial (Coronary Computed Tomography Angiography, Standard Treatment)
Not yet recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Computed Tomography Angiography
- Standard Treatment
- (no location specified)
Jul 3, 2022
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Cardiology, Infant Development, Development Delay Trial in Boston (NIDCAP Developmental Care)
Not yet recruiting
- Cardiology
- +2 more
- NIDCAP Developmental Care
-
Boston, MassachusettsBoston Children's Hospital
May 31, 2023
Coronary Heart Disease Trial in Canada, United States (Dalcetrapib (RO4607381), Placebo)
Completed
- Coronary Heart Disease
- Dalcetrapib (RO4607381)
- Placebo
-
Jacksonville, Florida
- +11 more
Dec 16, 2019
Congenital Heart Disease Trial in Atlanta (High Flow Nasal Canula following extubation, Non-Invasive Positive Pressure
Not yet recruiting
- Congenital Heart Disease
- High Flow Nasal Canula following extubation
- Non-Invasive Positive Pressure Ventilation following extubation
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
May 19, 2023
Coronary Heart Disease Trial in Cleveland (PAL2, CINEMA)
Recruiting
- Coronary Heart Disease
- PAL2
- CINEMA
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jun 15, 2023
Heart Defects, Congenital, Pulmonary Arterial Hypertension, Genetic Testing Trial in Leuven (Genetic testing)
Recruiting
- Heart Defects, Congenital
- +2 more
- Genetic testing
-
Leuven, BelgiumUniversity Hospitals Leuven
May 17, 2022
Congenital Heart Disease, Child Development, Early Intervention Trial in Porto Alegre (Remotely monitored parent-mediated hybrid
Recruiting
- Congenital Heart Disease
- +2 more
- Remotely monitored parent-mediated hybrid home and clinic based multidisciplinary Early Intervention protocols.
-
Porto Alegre, Rio Grande Do Sul, Brazil
- +1 more
Jun 8, 2023
Depressed Patients With Coronary Heart Disease - R01HL147862
Recruiting
- Coronary Heart Disease
- Depression
- Other
-
Saint Louis, MissouriWashington University
Mar 30, 2022